vaccine | GovernmentCIO Media & Research


The pandemic has caused a paradigm shift in biotech manufacturing and the global supply chain.
The agency is updating its guidance around vaccine authorization and will require investments in technology for its distribution.
Federal leaders emphasize the role of data in vaccine and treatment development, economic relief funding and contact tracing.